Building stronger people, systems, and outcomes in the GLP-1 era.
The next era of health benefits won’t be bought. It will be built. I help organizations shift from paying for sickness to designing for strength.
People want to be healthy. They want to thrive.
Many see GLP-1s as the solution.
Without a solid strategy, providing access will increase utilization – but not necessarily improve outcomes.
Solving for this requires a deeper understanding of the problem – and a carefully-crafted strategy.

Speaking
Dr. Younglove’s superpower is translating the complex science into something understandable – and helping craft solutions that work.
Obesity: The Problem You Can’t Afford to Ignore
Framing obesity as a personal problem, excluded from the halls of medicine, has had devastating consequences – individually and collectively.
Obesity: An Economic Problem
Obesity and obesity-related diseases negatively affect the economic health of organizations
An Unequal Burden:
How healthcare policies contribute to economic inequalities for women
When Biology Changes the Rules
Clinical Insights into Weight, Hormones, and Midlife Health
Meet Dr. Younglove:
Courtney Younglove, MD, FOMA, FACOG, DABOM, MSCP, is a physician, entrepreneur, and keynote speaker who helps leaders rethink how health is designed, delivered, and measured. Double board-certified in Obesity Medicine and Obstetrics & Gynecology, she is a Fellow of the Obesity Medicine Association and serves on its Board of Trustees.
As the founder of Heartland Weight Loss and co-founder of Sleep Fitter, she has built and led businesses at the intersection of medicine, metabolism, and human performance. Her experience spans patient care, benefit strategy, and executive education – giving her a rare perspective on how clinical decisions, culture, and cost structures intersect.
Dr. Younglove’s message is direct: drugs can change appetite, but systems determine outcomes. She helps employers, health plans, and health systems design benefits and care pathways that improve health and retention while controlling cost. Quoted by outlets such as Reuters, Medscape, and Glamour, she translates complex medical science into strategic insight for business audiences seeking a smarter path forward in the GLP-1 era.
Just fantastic!! Wonderful speaker and excellent balance of research review and practical clinical application! Thank you!
Program Attendee

Writing
Dr. Younglove speaks with her pen – loudly!
-
Evolutionary Mismatch?
Since I began practicing Obesity Medicine, I have been telling patients that obesity is a consequence of an environmental mismatch; how our bodies are designed to function (eat, sleep, move, connect, etc.) is radically different from how we currently live. Having excess weight is a common outcome of this mismatch, although it certainly isn’t the…
-
News that is anti-sensational?
“Over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug” I am cynical when it comes to news – it so often exaggerates and makes sensational claims. In fact I haven’t watched a single news program in five years. I get enough from my daily 1440 news email (just…

